Connection

Petri Kovanen to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Petri Kovanen has written about Dose-Response Relationship, Drug.
Petri Kovanen
Connection Strength
0.010
Dose-Response Relationship, Drug
  1. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. Biochem Biophys Res Commun. 2006 Aug 18; 347(1):31-5.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.